Tissue engineering has emerged as a new treatment approach for bone repair and
regeneration seeking to address limitations associated with current therapies, such as …

The role of native (not culture-expanded) joint-resident mesenchymal stem cells (MSCs) in
the repair of joint damage in osteoarthritis (OA) is poorly understood. MSCs differ from bone …

Introduction: The heterogeneous pool of cells found in the stromal vascular fraction of
adipose tissue (SVF) and the purified mesenchymal stromal/stem cells (ASCs) isolated from …

The popularity of adipose-derived cell therapy has increased over the last decade, and the
number of studies published annually is growing. However, concerns regarding safety in the …

Cell-based therapies are a promising alternative to grafts and organ transplantation for
treating tissue loss or damage due to trauma, malfunction, or disease. Over the past two …

Chronic musculoskeletal (MSK) pain is one of the most common medical complaints
worldwide and musculoskeletal injuries have an enormous social and economical impact …

Autologous adipose stromal vascular fractions (SVFs) containing adipose tissue-derived
stem cells (ASCs) are currently being used in clinical settings for various orthopedic …

Bone regeneration is a complex, well-orchestrated process based on the interactions
between osteogenesis and angiogenesis, observed in both physiological and pathological …

Some of the earliest success in de novo tissue generation was in bone tissue, and
advances, facilitated by the use of endogenous and exogenous progenitor cells, continue …

Aim The objective of the present review was to answer the focused question: what is the
effect of cell therapy in terms of orofacial bone regeneration compared to grafting with only …